FUJIFILM Biotechnologies Opens £400M UK Biomanufacturing Expansion in Teesside

FUJIFILM Biotechnologies expanded manufacturing and process development presence in the North East of England to support vital biomanufacturing innovativ...

February 12, 2026 | Thursday | News
Slingshot Biosciences Strengthens UK and EU Presence with Synthetic Cell Mimic Technology

Life sciences innovator and leader in precision-engineered synthetic cell mimic technology expands its UK/EU operations to accelerate cell and gene thera...

February 06, 2026 | Friday | News
10x Genomics Powers UK PharosAI Initiative to Build Multimodal Cancer Dataset

Initiative will create one of the world's largest multimodal cancer datasets and an integrated suite of AI models and tools to fuel p...

February 06, 2026 | Friday | News
Scancell Secures FDA IND Clearance for Registrational Phase 3 iSCIB1+ Melanoma Trial

Unlocks path towards registrational Phase 3 trial planned to start in 2026 Data from Phase 2 SCOPE trial show iSCIB1+ has potential to redefine standard...

January 27, 2026 | Tuesday | News
Stablepharma and AFT Pharmaceuticals Partner to Develop Fridge-Free Sterile Injectables for Global Markets

  Stablepharma Limited, specialists in thermostable formulations,announced a development and option-to-license agreement with AFT Pharmaceuticals to ...

January 16, 2026 | Friday | News
Bridging the Biopharma Skills Gap: How Virtual Reality Is Training the Next Generation of Medicine Makers

As the UK races to secure its position as a global leader in advanced therapies, a growing skills gap threatens to undermine billions in investment and pat...

January 14, 2026 | Wednesday | Interview
Oxford Nanopore’s GridION™ Dx Receives CE and UKCA Marking in UK and Europe

Oxford Nanopore has reached a major regulatory milestone with the registration of its first In Vitro Diagnostic (“IVD”) device in the UK an...

January 13, 2026 | Tuesday | Regulatory
Nucleome Therapeutics Nominates First-in-Class Monoclonal Antibody Programme Targeting Inflammation Resolution

First-in-class monoclonal antibody agonist programme for inflammation resolution with broad applicability across major chronic inflammatory diseases...

January 08, 2026 | Thursday | News
Mereo BioPharma’s Phase 3 Setrusumab Studies Miss Primary Fracture Endpoints in Osteogenesis Imperfecta

Neither study achieved its primary endpoint of reduction in annualized clinical fracture rate compared to placebo (ORBIT) or bisphosphonates (COSMIC) Bo...

December 31, 2025 | Wednesday | News
Symbiosis Manufactures First 10,000-Vial Batch at New Stirling Sterile Fill-Finish Facility

Symbiosis Pharmaceutical Services (Symbiosis), a leading sterile fill finish contract manufacturing organisation (CMO), has manufactured their first 10,0...

December 24, 2025 | Wednesday | News
Symeres Secures SBTi Approval for Science-Based Emissions Reduction Targets

Symeres, a leading contract research, development, and manufacturing organisation (CRDMO), has received its first approval from the Science Based Targets i...

December 19, 2025 | Friday | News
Norgine Secures Exclusive Rights to Vir Biotechnology’s Hepatitis Delta Combination Therapy

Agreement underscores Norgine's mission to bring innovative therapies to patients and builds on our heritage in hepatology and specialty pharmaceutical...

December 18, 2025 | Thursday | News
Lindus Health and Quotient Sciences Form Strategic Partnership to Accelerate Early-Phase Clinical Development

Lindus Health, the "anti-CRO" running radically faster, more  reliable clinical trials for life science pioneers, and Quotient Sciences, a leading g...

December 17, 2025 | Wednesday | News
Oxford BioTherapeutics and GSK Launch Multi-Year Collaboration to Develop Novel Antibody-Based Cancer Therapies

Collaboration leverages OBT's proprietary OGAP®-Verify platform and GSK's drug development expertise to advance multiple selected novel oncology ta...

December 11, 2025 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close